The role of gut microbiota in intestinal and liver diseases
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, přehledy
PubMed
30580671
DOI
10.1177/0023677218818605
Knihovny.cz E-zdroje
- Klíčová slova
- cancer, coeliac disease, dysbiosis, inflammatory bowel disease, non-alcoholic fatty liver disease,
- MeSH
- dysbióza mikrobiologie patofyziologie MeSH
- gnotobiologické modely fyziologie MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- nemoci jater mikrobiologie patofyziologie MeSH
- nemoci střev mikrobiologie patofyziologie MeSH
- střevní mikroflóra fyziologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The world-wide incidence of many immune-mediated and metabolic diseases, including those of the intestines and liver, is steadily increasing. Gut microbiota plays a central role in the pathogenesis of these diseases as it mediates environmental changes to the intestinal immune system. Various environmental factors including diet, food additives and medication also trigger the compositional and functional alterations of microbiota, that is, dysbiosis, and this dysbiosis is closely associated with many chronic inflammatory diseases. However, the causal relationship remains unclear for the majority of these diseases. In this review, we discuss essential epidemiological data, known pathogenetic factors including those of genetic and environmental nature, while mainly focusing on the role of gut microbiota in the development of selected intestinal and liver diseases. Using specific examples, we also briefly describe some of the most widely-used animal models including gnotobiotic models and their contribution to the research of pathogenetic mechanisms of the host-microbiota relationship.
Faculty of Medicine Charles University Czech Republic
Institute of Microbiology The Czech Academy of Sciences Czech Republic
Citace poskytuje Crossref.org